Status:
RECRUITING
Evolution of Respiratory Function in Lung Transplant Patients With Moderate to Severe Covid-19 Infection
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
COVID-19 Respiratory Infection
Eligibility:
All Genders
18+ years
Brief Summary
The SARS-Cov-2 infection pandemic has caused a large number of acute respiratory failures and deaths across the world. Certain factors have been identified as associated with a higher risk of developi...
Eligibility Criteria
Inclusion
- Adult patient
- Lung transplant patient (monopulmonary or bipulmonary)
- Covid diagnosed by RT-PCR between March 1, 2020 and December 31, 2022
- Hospitalization at the University Hospitals of Strasbourg for COVID-19
- Patient followed in the context of their lung transplant at the University Hospitals of Strasbourg
- Absence of written opposition in the subject's medical file to the reuse of their data for scientific research purposes.
Exclusion
- Subject having expressed his opposition to the reuse of his data for scientific research purposes.
Key Trial Info
Start Date :
September 4 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06490744
Start Date
September 4 2023
End Date
December 31 2024
Last Update
July 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'Anesthésie Réanimation - CHU de Strasbourg - France
Strasbourg, France, 67091